4-aminophenyl alpha-d-mannopyranoside has been researched along with isoniazid in 1 studies
| Studies (4-aminophenyl alpha-d-mannopyranoside) | Trials (4-aminophenyl alpha-d-mannopyranoside) | Recent Studies (post-2010) (4-aminophenyl alpha-d-mannopyranoside) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 21 | 0 | 10 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | 4-aminophenyl alpha-d-mannopyranoside (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, A; Goyal, AK; Grobler, A; Jain, AK; Mehta, A; Rath, G | 1 |
1 other study(ies) available for 4-aminophenyl alpha-d-mannopyranoside and isoniazid
| Article | Year |
|---|---|
Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis.
Topics: Administration, Inhalation; Aniline Compounds; Animals; Antitubercular Agents; Cells, Cultured; Ciprofloxacin; Drug Carriers; Drug Combinations; Drug Liberation; Hydrogen-Ion Concentration; Isoniazid; Liposomes; Macrophages, Alveolar; Male; Mannosides; Mice; Powders; Tuberculosis, Pulmonary | 2016 |